207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014...
Transcript of 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014...
![Page 1: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/1.jpg)
CENTER FOR DRUG EVALUATION AND RESEARCH
APPLICATION NUMBER:
207026Orig1s000
CHEMISTRY REVIEW(S)
![Page 2: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/2.jpg)
![Page 3: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/3.jpg)
![Page 4: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/4.jpg)
![Page 5: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/5.jpg)
![Page 6: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/6.jpg)
![Page 7: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/7.jpg)
![Page 8: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/8.jpg)
![Page 9: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/9.jpg)
![Page 10: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/10.jpg)
---------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signedelectronically and this page is the manifestation of the electronicsignature.---------------------------------------------------------------------------------------------------------/s/----------------------------------------------------
VIBHAKAR J SHAH11/26/2014
MAHESH R RAMANADHAM11/26/2014
Reference ID: 3664816
![Page 11: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/11.jpg)
Reference ID: 3690411
![Page 12: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/12.jpg)
Reference ID: 3690411
![Page 13: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/13.jpg)
Reference ID: 3690411
![Page 14: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/14.jpg)
![Page 15: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/15.jpg)
![Page 16: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/16.jpg)
Reference ID: 3690411
![Page 17: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/17.jpg)
![Page 18: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/18.jpg)
![Page 19: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/19.jpg)
![Page 20: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/20.jpg)
![Page 21: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/21.jpg)
![Page 22: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/22.jpg)
![Page 23: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/23.jpg)
![Page 24: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/24.jpg)
![Page 25: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/25.jpg)
![Page 26: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/26.jpg)
![Page 27: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/27.jpg)
![Page 28: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/28.jpg)
![Page 29: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/29.jpg)
![Page 30: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/30.jpg)
![Page 31: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/31.jpg)
![Page 32: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/32.jpg)
![Page 33: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/33.jpg)
![Page 34: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/34.jpg)
![Page 35: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/35.jpg)
![Page 36: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/36.jpg)
![Page 37: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/37.jpg)
![Page 38: 207026Orig1s000 - Food and Drug Administration · Sub ect Reviewer CMC Memo to File NDA 18 Dec 2014 Phoxillium Re lacement Solution A roval recommendation Dr. Olen Ste hens Pursuant](https://reader033.fdocuments.in/reader033/viewer/2022042016/5e747825f77488442a640743/html5/thumbnails/38.jpg)
---------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signedelectronically and this page is the manifestation of the electronicsignature.---------------------------------------------------------------------------------------------------------/s/----------------------------------------------------
KASTURI SRINIVASACHAR04/28/2014
OKPONANABOFA ERADIRI04/29/2014
ANGELICA DORANTES04/29/2014
OLEN M STEPHENS04/29/2014
Reference ID: 3497120